Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 11, 2019
Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study.
Journal: Rheumatology (Oxford, England)
Published: December 21, 2017
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
Journal: Pediatric rheumatology online journal
Published: September 05, 2017
Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.
Journal: International journal of rheumatic diseases
Published: March 23, 2017
In Vitro and In Vivo Investigation of Potential for Complex CYP3A Interaction for PF-00251802 (Dagrocorat), a Novel Dissociated Agonist of the Glucocorticoid Receptor.
Journal: Clinical pharmacology in drug development
Published: December 15, 2016
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.
Journal: Clinical pharmacology and therapeutics
Published: July 13, 2016
Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food.
Journal: Journal of clinical pharmacology
Published: January 26, 2016
Model-based drug development: a rational approach to efficiently accelerate drug development.
Journal: Clinical pharmacology and therapeutics
Published: April 17, 2013
Determination of dopamine D₂ receptor occupancy by lurasidone using positron emission tomography in healthy male subjects.
Journal: Psychopharmacology
Published: September 13, 2012
Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate.
Journal: The Journal of rheumatology
Published: March 03, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026